ARPF congratulates Dr. Kivipelto for this prestigious award

ARPF offers our warmest congratulations to Miia Kivipelto, MD, PhD on winning the 2020 Hyman Prize– an annual international award for $250,000 in recognition for the best work, invention, idea, or research carried out anywhere in the world that has enhanced the quality of life for older adults. Receiving this prestigious award is no small feat! It is the richest prize of its kind in the world.

Dr. Kivipelto has made huge strides in Alzheimer’s prevention over the last 20 years, most notably as the principal investigator of the renowned FINGER study. Dr. Kivipelto was chosen for this year’s prize for her tireless dedication to her research and her far-reaching impact around the world. She is a member of the ARPF Scientific Advisory Council and guest speaker for ARPF’s Brain Longevity® Therapy Training. Dr. Kivipelto’s research falls directly in line with ARPF’s 4 Pillars of Prevention®. She explained, “The failure rate in Alzheimer’s Disease drugs under development is 99.6% and there have been no new drugs approved since 2002. There is no miracle cure. Our research focuses on identifying who is at risk and finding ways they can reduce these risk factors. It isn’t just one solution – but there are a whole lot of things we can do to reduce the risk.’’

Hyman Prize Director David King said, “Our jury thought she was an outstanding candidate. Professor Kivipelto’s research is world-leading, practical and influential. She leads a team of 100 researchers and clinical staff working on the challenge and her colleagues describe her as a very hard-working scientist who is absolutely dedicated to understanding disease and improving life for older people.’’

ARPF has been a proud supporter of the FINGER study since its inception. Dr. Kivipelto’s brilliance is paving a way for safe, effective, and affordable Alzheimer’s prevention.